KDR and neoplasm: Several studies have focused on the vascular endothelial growth factor (VEGF)/vascular endothelial growth factor receptor 2 (VEGFR2) axis, which can trigger multiple downstream signaling pathways [6], causing tumor cell proliferation, migration, and angiogenesis.